For reprint rights or to purchase a copy of your Daily Journal photo, email jeremy@reprintpros.com for prices or call 949-702-5390.

To buy more copies, call 866-531-1492 or email subscribe@dailyjournal.com
This is the property of the Daily Journal Corporation and fully protected by copyright. It is made available only to Daily Journal subscribers for personal or collaborative purposes and may not be distributed, reproduced, modified, stored or transferred without written permission. Please click "Reprint" to order presentation-ready copies to distribute to clients or use in commercial marketing materials or for permission to post on a website. and copyright (showing year of publication) at the bottom.
Subscribe to the Daily Journal for access to Daily Appellate Reports, Verdicts, Judicial Profiles and more...
You have to be a subscriber to view this page.

Health Care & Hospital Law,
Civil Litigation

Apr. 25, 2022

Pharmaceutical companies face big battle in San Francisco

U.S. District Judge Charles Breyer of the Northern District of California will preside over the bench trial between the city and four corporate defendants: Walgreens Co., AbbVie Inc.’s Allergan, Teva Pharmaceutical Industries Ltd., and Teva Pharmaceutical Industries Ltd.’s Anda.

With opening arguments set to begin Monday in San Francisco’s case against the opioid supply chain, pharmaceutical companies face one of their biggest battles yet.

U.S. District Judge Charles Breyer of the Northern District of California will preside over the bench trial between the city and four corporate defendants: Walgreens Co., AbbVie Inc.’s Allergan, Teva Pharmaceutical Industries Ltd., and Teva Pharmaceutical Industries Ltd.’s Anda....

To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!

Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)

Already a subscriber?

Enewsletter Sign-up



By using our website, you agree to our use of cookies in accordance with our cookie policy. You can learn more about how we use cookies by reviewing our Privacy Policy here.